CAR T-cell therapy in diffuse large B-cell lymphoma: a practical resource for nurses
"Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Basel
S. Karger
2021
|
| Schriftenreihe: | Fast facts
|
| Online-Zugang: | DE-19 Volltext |
| Zusammenfassung: | "Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such, CD19-targeted chimeric antigen receptor (CAR) T-cell therapy has become the new standard of care for patients with relapsed or refractory DLBCL after at least two prior lines of therapy. It is an exciting new therapeutic intervention that is integral to the concept of personalized medicine"--Publisher's description |
| Beschreibung: | 1 online resource (96 Seiten) Illustrationen, Diagramme |
| ISBN: | 9783318069358 3318069353 |
| DOI: | 10.1159/isbn.978-3-318-06935-8 |
Internformat
MARC
| LEADER | 00000nam a22000001c 4500 | ||
|---|---|---|---|
| 001 | BV047807027 | ||
| 003 | DE-604 | ||
| 005 | 20241217 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 220131s2021 xx a||| o|||| 00||| eng d | ||
| 020 | |a 9783318069358 |9 978-3-318-06935-8 | ||
| 020 | |a 3318069353 |q (electronic book) |9 3318069353 | ||
| 024 | 7 | |a 10.1159/isbn.978-3-318-06935-8 |2 doi | |
| 035 | |a (OCoLC)1296278073 | ||
| 035 | |a (DE-599)HEB486211304 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-355 |a DE-384 | ||
| 100 | 1 | |a Buka, Richard J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a CAR T-cell therapy in diffuse large B-cell lymphoma |b a practical resource for nurses |c Richard J. Buka, Deirdre Moloney |
| 246 | 1 | 3 | |a Fast facts: CAR T-cell therapy in diffuse large B-cell lymphoma |
| 264 | 1 | |a Basel |b S. Karger |c 2021 | |
| 300 | |a 1 online resource (96 Seiten) |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Fast facts | |
| 520 | 3 | |a "Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such, CD19-targeted chimeric antigen receptor (CAR) T-cell therapy has become the new standard of care for patients with relapsed or refractory DLBCL after at least two prior lines of therapy. It is an exciting new therapeutic intervention that is integral to the concept of personalized medicine"--Publisher's description | |
| 700 | 1 | |a Moloney, Deirdre |e Verfasser |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-3-318-07024-8 |
| 856 | 4 | 0 | |u https://doi.org/10.1159/isbn.978-3-318-06935-8 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ZDB-25-KFF | ||
| 912 | |a ZDB-4-EOAC | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-033190626 | |
| 966 | e | |u https://doi.org/10.1159/isbn.978-3-318-06935-8 |l DE-19 |p ZDB-25-KFF |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1818685523497058304 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Buka, Richard J. Moloney, Deirdre |
| author_facet | Buka, Richard J. Moloney, Deirdre |
| author_role | aut aut |
| author_sort | Buka, Richard J. |
| author_variant | r j b rj rjb d m dm |
| building | Verbundindex |
| bvnumber | BV047807027 |
| collection | ZDB-25-KFF ZDB-4-EOAC |
| ctrlnum | (OCoLC)1296278073 (DE-599)HEB486211304 |
| doi_str_mv | 10.1159/isbn.978-3-318-06935-8 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a22000001c 4500</leader><controlfield tag="001">BV047807027</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20241217</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220131s2021 xx a||| o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783318069358</subfield><subfield code="9">978-3-318-06935-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3318069353</subfield><subfield code="q">(electronic book)</subfield><subfield code="9">3318069353</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1159/isbn.978-3-318-06935-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1296278073</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HEB486211304</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-384</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Buka, Richard J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">CAR T-cell therapy in diffuse large B-cell lymphoma</subfield><subfield code="b">a practical resource for nurses</subfield><subfield code="c">Richard J. Buka, Deirdre Moloney</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Fast facts: CAR T-cell therapy in diffuse large B-cell lymphoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">S. Karger</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (96 Seiten)</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Fast facts</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such, CD19-targeted chimeric antigen receptor (CAR) T-cell therapy has become the new standard of care for patients with relapsed or refractory DLBCL after at least two prior lines of therapy. It is an exciting new therapeutic intervention that is integral to the concept of personalized medicine"--Publisher's description</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moloney, Deirdre</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-3-318-07024-8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1159/isbn.978-3-318-06935-8</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-25-KFF</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EOAC</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033190626</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1159/isbn.978-3-318-06935-8</subfield><subfield code="l">DE-19</subfield><subfield code="p">ZDB-25-KFF</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV047807027 |
| illustrated | Illustrated |
| index_date | 2024-07-03T19:03:59Z |
| indexdate | 2024-12-17T11:07:53Z |
| institution | BVB |
| isbn | 9783318069358 3318069353 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033190626 |
| oclc_num | 1296278073 |
| open_access_boolean | 1 |
| owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-384 |
| owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-384 |
| physical | 1 online resource (96 Seiten) Illustrationen, Diagramme |
| psigel | ZDB-25-KFF ZDB-4-EOAC |
| publishDate | 2021 |
| publishDateSearch | 2021 |
| publishDateSort | 2021 |
| publisher | S. Karger |
| record_format | marc |
| series2 | Fast facts |
| spelling | Buka, Richard J. Verfasser aut CAR T-cell therapy in diffuse large B-cell lymphoma a practical resource for nurses Richard J. Buka, Deirdre Moloney Fast facts: CAR T-cell therapy in diffuse large B-cell lymphoma Basel S. Karger 2021 1 online resource (96 Seiten) Illustrationen, Diagramme txt rdacontent c rdamedia cr rdacarrier Fast facts "Diffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma. While treatment with immunochemotherapy has generally shown good outcomes, specific subgroups of patients with high-risk disease have an unfavorable prognosis. Extensive efforts have been made to improve outcomes in these patients. As such, CD19-targeted chimeric antigen receptor (CAR) T-cell therapy has become the new standard of care for patients with relapsed or refractory DLBCL after at least two prior lines of therapy. It is an exciting new therapeutic intervention that is integral to the concept of personalized medicine"--Publisher's description Moloney, Deirdre Verfasser aut Erscheint auch als Druck-Ausgabe 978-3-318-07024-8 https://doi.org/10.1159/isbn.978-3-318-06935-8 Verlag kostenfrei Volltext |
| spellingShingle | Buka, Richard J. Moloney, Deirdre CAR T-cell therapy in diffuse large B-cell lymphoma a practical resource for nurses |
| title | CAR T-cell therapy in diffuse large B-cell lymphoma a practical resource for nurses |
| title_alt | Fast facts: CAR T-cell therapy in diffuse large B-cell lymphoma |
| title_auth | CAR T-cell therapy in diffuse large B-cell lymphoma a practical resource for nurses |
| title_exact_search | CAR T-cell therapy in diffuse large B-cell lymphoma a practical resource for nurses |
| title_exact_search_txtP | CAR T-cell therapy in diffuse large B-cell lymphoma a practical resource for nurses |
| title_full | CAR T-cell therapy in diffuse large B-cell lymphoma a practical resource for nurses Richard J. Buka, Deirdre Moloney |
| title_fullStr | CAR T-cell therapy in diffuse large B-cell lymphoma a practical resource for nurses Richard J. Buka, Deirdre Moloney |
| title_full_unstemmed | CAR T-cell therapy in diffuse large B-cell lymphoma a practical resource for nurses Richard J. Buka, Deirdre Moloney |
| title_short | CAR T-cell therapy in diffuse large B-cell lymphoma |
| title_sort | car t cell therapy in diffuse large b cell lymphoma a practical resource for nurses |
| title_sub | a practical resource for nurses |
| url | https://doi.org/10.1159/isbn.978-3-318-06935-8 |
| work_keys_str_mv | AT bukarichardj cartcelltherapyindiffuselargebcelllymphomaapracticalresourcefornurses AT moloneydeirdre cartcelltherapyindiffuselargebcelllymphomaapracticalresourcefornurses AT bukarichardj fastfactscartcelltherapyindiffuselargebcelllymphoma AT moloneydeirdre fastfactscartcelltherapyindiffuselargebcelllymphoma |